Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0027051|myocardial infarction
Sentences 21
PubMedID- 25563711 Conclusions: this prospective observational cohort trial demonstrated that chronic ace-i therapy was an independent predictor for reduced periprocedural myocardial infarction among patients with metabolic syndrome who underwent elective coronary intervention.
PubMedID- 22971940 Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction.
PubMedID- 21159478 Acute inferior myocardial infarction with nephrotic syndrome.
PubMedID- 23715346 The study was aimed to find out the impact of metabolic syndrome in patients with acute myocardial infarction during hospital stay.
PubMedID- 23411742 Aim: aim of this study was to determine the prevalence of metabolic syndrome in patients with premature myocardial infarction (before 50 years of age).
PubMedID- 22701134 The aim of this study was to evaluate clinical impact of non-hdl-c and apob on clinical outcomes in metabolic syndrome (ms) patients with acute myocardial infarction (ami) undergoing percuatneous coronary intervetion.
PubMedID- 20811489 We sought to determine and compare the prevalence of the metabolic syndrome (ms) in patients with acute myocardial infarction (ami) utilizing the new international diabetes federation (idf) definition with the older national cholesterol education program (ncep) definition.
PubMedID- 19356813 Obesity and the metabolic syndrome in patients with acute myocardial infarction.
PubMedID- 23934969 Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des).
PubMedID- 21646744 Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome.
PubMedID- 25789257 In the present study we aimed to compare myocardial infarction size in patients with metabolic syndrome to those without metabolic syndrome using peak ck-mb and cardiac troponin i (ctni) at 72 hours after the onset of symptoms.
PubMedID- 21428179 Conclusion: elevated homocysteine levels were correlated to the metabolic syndrome in patients with prior myocardial infarction.
PubMedID- 20509277 Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction).
PubMedID- 22263382 Metabolic syndrome and outcome in patients with acute myocardial infarction.
PubMedID- 21757819 Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms).
PubMedID- 26309630 The positive therapeutic effect in a patient of evans syndrome combined with acute myocardial infarction.
PubMedID- 20890426 We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes.
PubMedID- 21418805 [antiphospholipid syndrome complicated with acute myocardial infarction: a case report].
PubMedID- 24020829 Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome.
PubMedID- 22240598 Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction.
PubMedID- 21487455 Patient was diagnosed with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, further complicated by non-st elevation myocardial infarction (nstemi), and acute pancreatitis based on the peripheral smear, thrombocytopenia, hemolytic anemia, acute renal failure, elevated cardiac biomarkers and elevated pancreatic enzymes.

Page: 1